QUERCUS ALBA POLLEN: 56 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
56
Total FAERS Reports
0
Deaths Reported
5
Hospitalizations
56
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20160504 · Latest Report: 20240409
What Are the Most Common QUERCUS ALBA POLLEN Side Effects?
#1 Most Reported
Anaphylactic reaction
16 reports (28.6%)
#2 Most Reported
Injection site urticaria
8 reports (14.3%)
#3 Most Reported
Injection site erythema
8 reports (14.3%)
All QUERCUS ALBA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic reaction | 16 | 28.6% | 0 | 2 |
| Injection site erythema | 8 | 14.3% | 0 | 1 |
| Injection site urticaria | 8 | 14.3% | 0 | 1 |
| Injection site reaction | 7 | 12.5% | 0 | 0 |
| Pruritus | 7 | 12.5% | 0 | 0 |
| Urticaria | 7 | 12.5% | 0 | 0 |
| Local reaction | 6 | 10.7% | 0 | 1 |
| Dyspnoea | 5 | 8.9% | 0 | 2 |
| False negative investigation result | 5 | 8.9% | 0 | 1 |
| Injection site swelling | 5 | 8.9% | 0 | 0 |
Who Reports QUERCUS ALBA POLLEN Side Effects? Age & Gender Data
Gender: 39.3% female, 60.7% male. Average age: 35.0 years. Most reports from: US. View detailed demographics →
Is QUERCUS ALBA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 7 | 0 | 0 |
| 2017 | 4 | 0 | 0 |
| 2018 | 2 | 0 | 0 |
| 2020 | 5 | 0 | 1 |
| 2021 | 4 | 0 | 0 |
| 2022 | 16 | 0 | 2 |
| 2023 | 5 | 0 | 0 |
| 2024 | 1 | 0 | 1 |
What Is QUERCUS ALBA POLLEN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 14 |
| Skin test | 8 |
| Rhinitis allergic | 6 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for QUERCUS ALBA POLLEN
Official prescribing information from the FDA-approved drug label.